Perpetual Medicines secures $8m for peptide drug discovery platform
Perpetual Medicines, a frontrunner in computational peptide therapeutics, recently announced an impressive $8 million seed financing round, spearheaded by Chengwei Capital. This significant financial injection is set to bolster the company’s innovative platform for peptide drug discovery, marking a new chapter in the pharmaceutical industry. Integrating AI and Computational Design in Drug Discovery The core […]